Compare PLSE & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | REAL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.9B |
| IPO Year | 2015 | 2019 |
| Metric | PLSE | REAL |
|---|---|---|
| Price | $23.01 | $9.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $22.00 | $17.00 |
| AVG Volume (30 Days) | 233.4K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.55 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $692,845,000.00 |
| Revenue This Year | $840.00 | $14.30 |
| Revenue Next Year | $287.54 | $10.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.38 |
| 52 Week Low | $12.56 | $4.61 |
| 52 Week High | $26.30 | $17.39 |
| Indicator | PLSE | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 60.33 | 44.88 |
| Support Level | $13.75 | $7.21 |
| Resistance Level | $23.18 | $11.17 |
| Average True Range (ATR) | 1.32 | 0.53 |
| MACD | 0.08 | 0.15 |
| Stochastic Oscillator | 84.06 | 63.99 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.